These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 188760)

  • 21. Studies on diphtheria toxin. The effect of GTP on the toxin-dependent adenosine diphosphate ribosylation of rat liver aminoacyl transferase. II.
    Sperti S; Montanaro L; Mattioli A
    Chem Biol Interact; 1971 Apr; 3(2):141-8. PubMed ID: 4333440
    [No Abstract]   [Full Text] [Related]  

  • 22. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry.
    Jørgensen R; Merrill AR; Yates SP; Marquez VE; Schwan AL; Boesen T; Andersen GR
    Nature; 2005 Aug; 436(7053):979-84. PubMed ID: 16107839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eukaryotic elongation factor 2 loses its non-specific affinity for RNA and leaves polyribosomes as a result of ADP-ribosylation.
    Sitikov AS; Davydova EK; Bezlepkina TA; Ovchinnikov LP; Spirin AS
    FEBS Lett; 1984 Oct; 176(2):406-10. PubMed ID: 6208057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diphtheria toxin. Site and configuration of ADP-ribosylation of diphthamide in elongation factor 2.
    Oppenheimer NJ; Bodley JW
    J Biol Chem; 1981 Aug; 256(16):8579-81. PubMed ID: 6267047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
    Bell CE; Eisenberg D
    Biochemistry; 1996 Jan; 35(4):1137-49. PubMed ID: 8573568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular dichroism of diphtheria toxin, Pseudomonas aeruginosa exotoxin A, and various derivatives.
    Collins CM; Collier RJ
    Biochim Biophys Acta; 1985 Apr; 828(2):138-43. PubMed ID: 3919768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection and characterization of cells resistant to diphtheria toxin and pseudomonas exotoxin A: presumptive translational mutants.
    Moehring TJ; Moehring JM
    Cell; 1977 Jun; 11(2):447-54. PubMed ID: 408012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues.
    Saelinger CB; Snell K; Holder IA
    J Infect Dis; 1977 Oct; 136(4):555-61. PubMed ID: 409788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posttranslational modification of elongation factor 2 in diphtheria-toxin-resistant mutants of CHO-K1 cells.
    Moehring JM; Moehring TJ; Danley DE
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):1010-4. PubMed ID: 6928655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular ADP-ribosylation of elongation factor 2.
    Iglewski WJ
    Mol Cell Biochem; 1994 Sep; 138(1-2):131-3. PubMed ID: 7898455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-scale purification and characterization of the exotoxin of Pseudomonas aeruginosa.
    Leppla SH
    Infect Immun; 1976 Oct; 14(4):1077-86. PubMed ID: 11187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the elongation factor 2 gene which confer resistance to diphtheria toxin and Pseudomonas exotoxin A. Genetic and biochemical analyses.
    Foley BT; Moehring JM; Moehring TJ
    J Biol Chem; 1995 Sep; 270(39):23218-25. PubMed ID: 7559470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal assignment of the gene for human elongation factor 2.
    Kaneda Y; Yoshida MC; Kohno K; Uchida T; Okada Y
    Proc Natl Acad Sci U S A; 1984 May; 81(10):3158-62. PubMed ID: 6427766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined treatment with Pseudomonas aeruginosa toxin and interferon on mouse and human cells.
    Salzberg S; Parizade P; Nitzan Y
    Toxicon; 1989; 27(8):917-26. PubMed ID: 2476872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NAD binding site of diphtheria toxin: identification of a residue within the nicotinamide subsite by photochemical modification with NAD.
    Carroll SF; Collier RJ
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3307-11. PubMed ID: 6145155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of diphtheria toxin by NAD.
    Gill DM; Steinhaus DM
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(3):316-23. PubMed ID: 4371004
    [No Abstract]   [Full Text] [Related]  

  • 37. Estimating the amounts of ADP-ribosylatable active elongation factor-2 in mammalian cell-free extracts.
    Riis B; Rattan SI; Clark BF
    J Biochem Biophys Methods; 1989 Oct; 19(4):319-25. PubMed ID: 2693515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADP-ribosylating microbial toxins.
    Foster JW; Kinney DM
    Crit Rev Microbiol; 1985; 11(4):273-98. PubMed ID: 2859967
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation and properties of the trypsin-derived ADP-ribosyl peptide from diphtheria toxin-modified yeast elongation factor 2.
    Van Ness BG; Howard JB; Bodley JW
    J Biol Chem; 1978 Dec; 253(24):8687-90. PubMed ID: 721806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the mode of action of diphtheria toxin. VII. Toxin-stimulated hydrolysis of nicotinamide adenine dinucleotide in mammalian cell extracts.
    Gill DM; Pappenheimer AM; Brown R; Kurnick JT
    J Exp Med; 1969 Jan; 129(1):1-21. PubMed ID: 4304436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.